MagPure chip: an immunomagnetic-based microfluidic device for high purification of circulating tumor cells from liquid biopsies-Reference-Cited by-同舟云学术

MagPure chip: an immunomagnetic-based microfluidic device for high purification of circulating tumor cells from liquid biopsies

Published:2022 Issue:21 Volume:22 Page:4151-4166
ISSN:1473-0197
Container-title:Lab on a Chip
language:en
Short-container-title:Lab Chip

Author:

Descamps Lucie¹^ORCID,Garcia Jessica²,Barthelemy David²,Laurenceau Emmanuelle³,Payen Léa²,Le Roy Damien⁴,Deman Anne-Laure¹

Affiliation:

1. Institut des Nanotechnologies de Lyon, INL UMR5270, Université Claude Bernard Lyon 1, Villeurbanne, France

2. Laboratoire de Biochimie et Biologie Moléculaire, CICLY UR3738, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre Bénite, France

3. Institut des Nanotechnologies de Lyon, INL UMR5270, Ecole Centrale de Lyon, Ecully, France

4. Institut Lumière Matière, ILM UMR5306, Université Claude Bernard Lyon 1, Villeurbanne, France

Abstract

The isolation of circulating tumor cells (CTCs) directly from blood, as a liquid biopsy, could lead to a paradigm shift in cancer care. The MagPure chip provides a powerful tool for subsequent purification of CTCs and dissection of their clinical information.

Funder

Région Auvergne-Rhône-Alpes

Publisher

Royal Society of Chemistry (RSC)

Subject

Biomedical Engineering,General Chemistry,Biochemistry,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2022/LC/D2LC00443G

Reference75 articles.

1. American Cancer Society, 2021

2. Liquid biopsies for management of pancreatic cancer

3. The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies